Literature DB >> 24033445

Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer.

Chikara Ohyama1, Shingo Hatakeyama, Takahiro Yoneyama, Takuya Koie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24033445     DOI： 10.1111/iju.12230

Source DB:  PubMed          Journal:  Int J Urol        ISSN： 0919-8172            Impact factor:   3.369


× No keyword cloud information.
  8 in total

1.  Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.

Authors:  Ken Fukushi; Takuma Narita; Shingo Hatakeyama; Hayato Yamamoto; Osamu Soma; Teppei Matsumoto; Yuki Tobisawa; Tohru Yoneyama; Atsushi Imai; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Chikara Ohyama
Journal:  Int J Clin Oncol       Date:  2016-12-08       Impact factor: 3.402

2.  A retrospective analysis of incidence and its associated risk factors of upper urinary tract recurrence following radical cystectomy for bladder cancer with transitional cell carcinoma: the significance of local pelvic recurrence and positive lymph node.

Authors:  Sung Han Kim; Hyung-Kook Yang; Jung Hoon Lee; Eun-Sik Lee
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

Review 3.  Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review.

Authors:  Vishal Vashistha; David I Quinn; Tanya B Dorff; Siamak Daneshmand
Journal:  BMC Cancer       Date:  2014-12-16       Impact factor: 4.430

4.  Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.

Authors:  Yuka Kubota; Shingo Hatakeyama; Toshikazu Tanaka; Naoki Fujita; Hiromichi Iwamura; Jotaro Mikami; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hiroyuki Ito; Kazuaki Yoshikawa; Atsushi Sasaki; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Oncotarget       Date:  2017-10-06

5.  Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.

Authors:  Itsuto Hamano; Shingo Hatakeyama; Hiromichi Iwamurau; Naoki Fujita; Ken Fukushi; Takuma Narita; Kazuhisa Hagiwara; Ayumu Kusaka; Shogo Hosogoe; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hiroyuki Ito; Kazuaki Yoshikawa; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Oncotarget       Date:  2017-05-29

6.  Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.

Authors:  Ayumu Kusaka; Shingo Hatakeyama; Shogo Hosogoe; Itsuto Hamano; Hiromichi Iwamura; Naoki Fujita; Ken Fukushi; Takuma Narita; Kazuhisa Hagiwara; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hiroyuki Ito; Kazuaki Yoshikawa; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Oncotarget       Date:  2017-07-06

Review 7.  Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma.

Authors:  Hiromichi Iwamura; Shingo Hatakeyama; Makoto Sato; Chikara Ohyama
Journal:  Med Oncol       Date:  2018-05-09       Impact factor: 3.064

8.  Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.

Authors:  Go Anan; Shingo Hatakeyama; Naoki Fujita; Hiromichi Iwamura; Toshikazu Tanaka; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Hiroyuki Ito; Kazuaki Yoshikawa; Toshiaki Kawaguchi; Makoto Sato; Chikara Ohyama
Journal:  Oncotarget       Date:  2017-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.